The main objective of the project is to compare the effectiveness and efficiency of innovative care through the IsereADOM home-care service package versus standard care in the prevention of unplanned hospitalizations in patients with cancer treatment. In accordance with the recommendations of the French High Authority of Health (HAS), a cost-utility analysis (ACU) will be implemented
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Comparison of the effectiveness and efficiency of innovative care with the IsereADOM home-care service package versus standard support
Timeframe: 6 months
Incremental Cost-Utility Ratio comparison
Timeframe: 6 months